BACKGROUND: Peripheral artery disease (PAD) and its severe form, chronic limb-threatening ischemia (CLTI), significantly ...

Please provide your email address to receive an email when new articles are posted on . Among patients with diabetes and stable CAD, ticagrelor plus aspirin reduced ischemic limb events compared with ...

For decades, treatment of peripheral artery disease has focused almost exclusively on restoring blood flow. Now, new research ...

Women and Black patients are more likely to suffer life-changing complications from advanced heart and blood vessel procedures, a trio of new studies says. Persistent over-dilation of muscle ...

Phoenix, AZ (May 19, 2023)- New analysis of chronic limb-threatening ischemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular ...

The COVID-19 pandemic has had repercussions for patients with peripheral artery disease that range from increased amputations to payoffs in terms of efforts to keep patients out of hospitals while ...

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that early ...

Persistent over-dilation of muscle microvasculature may be one reason causing chronic limb-threatening ischemia, recent studies by Kuopio University Hospital and the University of Eastern Finland show ...

Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...

Lei Ye, M.D., Ph.D., associate professor in the Department of Biomedical Engineering, and his lab team have published groundbreaking research that proves specially designed nanovesicles—tiny particles ...